OtherLetters to the Editor
Potential theranostic role of bone marrow glucose metabolism on baseline [18F]-FDG PET/CT in metastatic melanoma
Romain-David Seban, Laurence Champion, Izza Muneer, Shwe Synn, Lawrence H. Schwartz and Laurent Dercle
Journal of Nuclear Medicine May 2021, jnumed.121.262361; DOI: https://doi.org/10.2967/jnumed.121.262361
Romain-David Seban
1 Institut Curie;
Laurence Champion
1 Institut Curie;
Izza Muneer
2 Department of Internal Medicine, Montefiore/Albert Einstein College of Medicine, Bronx, NY;
Shwe Synn
2 Department of Internal Medicine, Montefiore/Albert Einstein College of Medicine, Bronx, NY;
Lawrence H. Schwartz
3 Department of Radiology, New York Presbyterian Hospital, Columbia University Medical Center, New York, New York;
Laurent Dercle
4 Department of Radiology, New York Presbyterian Hospital, Columbia University Medical Center, United States
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Journal of Nuclear Medicine
Vol. 66, Issue 1
January 1, 2025
Potential theranostic role of bone marrow glucose metabolism on baseline [18F]-FDG PET/CT in metastatic melanoma
Romain-David Seban, Laurence Champion, Izza Muneer, Shwe Synn, Lawrence H. Schwartz, Laurent Dercle
Journal of Nuclear Medicine May 2021, jnumed.121.262361; DOI: 10.2967/jnumed.121.262361
Potential theranostic role of bone marrow glucose metabolism on baseline [18F]-FDG PET/CT in metastatic melanoma
Romain-David Seban, Laurence Champion, Izza Muneer, Shwe Synn, Lawrence H. Schwartz, Laurent Dercle
Journal of Nuclear Medicine May 2021, jnumed.121.262361; DOI: 10.2967/jnumed.121.262361
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.